SHU Meng-ni, LI Shu-chen. Effect of seru Msodiu Mon complications in patients with decompensated liver cirrhosis[J]. Chinese Hepatolgy, 2016, 21(1): 6-8.
1 李卫东,宫彦英,曲韬.肝硬化腹水低钠血症52例转归分析.现代医学,2004,32:95-96. 2 Jalan R,Hayes PC.Sodiu Mhandling inpatients with Compenstateed cirrhosis is dependent on the severity of liver disease ahd portal. Pressure Gut,2000,46:527. 3 许慧阳,侯为顺,蒯荟芬.血钠水平在肝硬化中的临床意义.实用全科医学,2006,4:278-279. 4 Guevara M,Gines P.Hyponatremia in liver cirrhosis:pathogenesis and treatment. Endocrinol Nutr,2010,57(Suppl 2):15-21. 5 Moreau R.Hyponatremia in cirrhosis. Pathophysiology,prevalence,prognostic value,treatment. Acta Gastroenterol Belg,2008,71:379-385. 6 Gross P.Treatment of hyponatremia.Intern Med,2008,47:885-891. 7 Gaglio P,Marfo K,Chiodo J3rd. Hyponatremia in cirrhosis and end-stage liver disease:treatment with the vasopressin V(2)-receptor antagonist tolvaptan. Dig Dis Sci,2012,57:2774-2785.